These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 20034593)
1. The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Peruzzi B; Araten DJ; Notaro R; Luzzatto L Mutat Res; 2010; 705(1):3-10. PubMed ID: 20034593 [TBL] [Abstract][Full Text] [Related]
2. A quantitative measurement of the human somatic mutation rate. Araten DJ; Golde DW; Zhang RH; Thaler HT; Gargiulo L; Notaro R; Luzzatto L Cancer Res; 2005 Sep; 65(18):8111-7. PubMed ID: 16166284 [TBL] [Abstract][Full Text] [Related]
3. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Miura D; Dobrovolsky VN; Kimoto T; Kasahara Y; Heflich RH Mutat Res; 2009; 677(1-2):86-92. PubMed ID: 19501187 [TBL] [Abstract][Full Text] [Related]
4. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression. Kimoto T; Suzuki K; Kobayashi XM; Dobrovolsky VN; Heflich RH; Miura D; Kasahara Y Mutat Res; 2011 Jul; 723(1):36-42. PubMed ID: 21549855 [TBL] [Abstract][Full Text] [Related]
5. The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells. Krüger CT; Hofmann M; Hartwig A Arch Toxicol; 2015 Dec; 89(12):2429-43. PubMed ID: 25417052 [TBL] [Abstract][Full Text] [Related]
6. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Dobrovolsky VN; Miura D; Heflich RH; Dertinger SD Environ Mol Mutagen; 2010; 51(8-9):825-35. PubMed ID: 20857433 [TBL] [Abstract][Full Text] [Related]
7. Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer. Chen R; Eshleman JR; Brodsky RA; Medof ME Cancer Res; 2001 Jan; 61(2):654-8. PubMed ID: 11212264 [TBL] [Abstract][Full Text] [Related]
8. In vivo mutation assay based on the endogenous Pig-a locus. Bryce SM; Bemis JC; Dertinger SD Environ Mol Mutagen; 2008 May; 49(4):256-64. PubMed ID: 18288722 [TBL] [Abstract][Full Text] [Related]
9. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Miura D; Dobrovolsky VN; Mittelstaedt RA; Kasahara Y; Katsuura Y; Heflich RH Environ Mol Mutagen; 2008 Oct; 49(8):622-30. PubMed ID: 18626996 [TBL] [Abstract][Full Text] [Related]
10. Monitoring humans for somatic mutation in the endogenous PIG-a gene using red blood cells. Dobrovolsky VN; Elespuru RK; Bigger CA; Robison TW; Heflich RH Environ Mol Mutagen; 2011 Dec; 52(9):784-94. PubMed ID: 21826740 [TBL] [Abstract][Full Text] [Related]
11. The in vitro PIG-A gene mutation assay: glycosylphosphatidylinositol (GPI)-related genotype-to-phenotype relationship in TK6 cells. Krüger CT; Fischer BM; Armant O; Morath V; Strähle U; Hartwig A Arch Toxicol; 2016 Jul; 90(7):1729-36. PubMed ID: 27100116 [TBL] [Abstract][Full Text] [Related]
12. Analysis of mutations in the Pig-a gene of spleen T-cells from N-ethyl-N-nitrosourea-treated fisher 344 rats. Miura D; Shaddock JG; Mittelstaedt RA; Dobrovolsky VN; Kimoto T; Kasahara Y; Heflich RH Environ Mol Mutagen; 2011 Jun; 52(5):419-23. PubMed ID: 21542029 [TBL] [Abstract][Full Text] [Related]
13. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Miura D; Dobrovolsky VN; Kasahara Y; Katsuura Y; Heflich RH Environ Mol Mutagen; 2008 Oct; 49(8):614-21. PubMed ID: 18626999 [TBL] [Abstract][Full Text] [Related]
14. Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria. Purow DB; Howard TA; Marcus SJ; Rosse WF; Ware RE Blood Cells Mol Dis; 1999 Apr; 25(2):81-91. PubMed ID: 10389589 [TBL] [Abstract][Full Text] [Related]
16. Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk Bemis JC; Avlasevich SL; Labash C; McKinzie P; Revollo J; Dobrovolsky VN; Dertinger SD Environ Mol Mutagen; 2018 Jan; 59(1):18-29. PubMed ID: 29115020 [TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of murine pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus. Kawagoe K; Takeda J; Endo Y; Kinoshita T Genomics; 1994 Oct; 23(3):566-74. PubMed ID: 7851884 [TBL] [Abstract][Full Text] [Related]
18. Glycosylphosphatidylinositol-linked proteins are required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Bessler M; Rosti V; Peng Y; Cattoretti G; Notaro R; Ohsako S; Elkon KB; Luzzatto L Eur J Immunol; 2002 Sep; 32(9):2607-16. PubMed ID: 12207345 [TBL] [Abstract][Full Text] [Related]
19. PIG-A gene abnormalities in Thai patients with paroxysmal nocturnal hemoglobinuria. Pramoonjago P; Wanachiwanawin W; Chinprasertsuk S; Pattanapanyasat K; Takeda J; Kinoshita T Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():322-4. PubMed ID: 8629134 [TBL] [Abstract][Full Text] [Related]
20. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]